Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human energy expenditure modelling research.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2018
Same author

Evaluation of P16 expression in canine appendicular osteosarcoma.

BMC veterinary research·2017
Same author

Expression and targeting of transcription factor ATF5 in dog gliomas.

Veterinary and comparative oncology·2017
Same author

Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.

Veterinary and comparative oncology·2016
Same author

Molecular signalling pathways in canine gliomas.

Veterinary and comparative oncology·2015
Same author

Pilot randomised controlled trial of a radiation therapist-led educational intervention for breast cancer patients prior to commencing radiotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2013

Related Experiment Video

Updated: May 28, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

TP53 mutations in canine brain tumors.

D York1, R J Higgins, R A LeCouteur

  • 1Department of Surgical and Radiological Sciences, Tupper Hall, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

Veterinary Pathology
|October 18, 2011
PubMed
Summary

Canine brain tumors rarely harbor TP53 gene mutations, unlike human cancers. This suggests alternative pathways may inactivate the p53 tumor suppressor in dogs.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

Related Experiment Videos

Last Updated: May 28, 2026

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
10:13

Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice

Published on: August 12, 2014

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

Area of Science:

  • Oncology
  • Genetics
  • Veterinary Medicine

Background:

  • The TP53 tumor suppressor gene is frequently altered in human cancers.
  • TP53 mutations are a key mechanism for p53 pathway inactivation in human brain tumors, especially astrocytomas.
  • Investigating TP53 in canine brain tumors can offer comparative insights into oncogenesis.

Purpose of the Study:

  • To determine the frequency of TP53 gene mutations in canine brain tumors.
  • To compare TP53 mutation rates in canine brain tumors with those reported in human tumors.
  • To explore potential alternative mechanisms of p53 inactivation in canine brain tumors.

Main Methods:

  • Sequencing of genomic DNA from 37 glial and 51 nonglial canine brain tumors.
  • Focus on mutations within exons 3-9 of the TP53 gene.
  • Analysis of mutation frequency in the overall cohort and specifically in astrocytic tumors.

Main Results:

  • TP53 exonic mutations were identified in 3 out of 88 canine brain tumors (3.4%).
  • A single mutation was found in 1 out of 18 astrocytic canine tumors (5.5%).
  • The observed mutation frequency is significantly lower than in comparable human brain tumors.

Conclusions:

  • TP53 gene mutations are infrequent in canine brain tumors.
  • Alternative mechanisms likely contribute to p53 pathway inactivation in canine brain tumors.
  • Further research is needed to understand p53's role in canine brain tumor development.